Endo Fights Class Cert. In Investors' Drug Price-Fixing Suit
Endo International challenged its shareholders' class certification bid in their generic drug price-fixing suit, arguing in Pennsylvania federal court that the Chicago pension fund seeking to represent the class fails to...To view the full article, register now.
Already a subscriber? Click here to view full article